Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B

Ceftriaxone, an FDA-approved third-generation cephalosporin antibiotic, has antimicrobial activity against both gram-positive and gram-negative organisms. Generally, ceftriaxone is used for a variety of infections such as community-acquired pneumonia, meningitis and gonorrhea. Its primary molecular...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Li, Xiang, Li, Haitao, Li, Shengqing, Zhu, Feng, Kim, Dong Joon, Xie, Hua, Li, Yan, Nadas, Janos, Oi, Naomi, Zykova, Tatyana A., Yu, Dong Hoon, Lee, Mee-Hyun, Kim, Myoung Ok, Wang, Lei, Ma, Weiya, Lubet, Ronald A., Bode, Ann M., Dong, Ziming, Dong, Zigang
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2012
Matèries:
Original Manuscript
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3510736/
https://ncbi.nlm.nih.gov/pubmed/22962305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgs283
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars